-
61
End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
Published 2024-03-01“…We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9. …”
Get full text
Article -
62
Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency
Published 2013-01-01“…Prognosis is very poor when bone marrow transplantation cannot be performed. We report the case of an infant with major histocompatibility complex class II expression deficiency revealed by hypoxemic bronchiolitis due to Pneumocystis jiroveci.…”
Get full text
Article -
63
Clinical Biology and Potential Use of Thrombopoietin
Published 2000-01-01“…They have also been shown to enhance platelet recovery after chemotherapy, but early results from trials investigating their ability to prevent severe thrombocytopenia associated with the treatment of leukemia and bone marrow transplantation have been disappointing. In addition, subcutaneous administration of one of these agents, megakaryocyte growth and development factor, has been shown to induce the formation of antibodies that neutralize native thrombopoietin and cause thrombocytopenia. …”
Get full text
Article -
64
-
65
-
66
Cellular Origins of Regenerating Nodules and Malignancy in the FAH Model of Liver Injury after Bone Marrow Cell Transplantation
Published 2016-01-01“…Using this strain as recipients, we performed bone marrow transplantation experiments. As a result, we could not demonstrate the presence of any epithelial cells except hepatocytes that were of donor origin in regenerating tissue, and no evidence of cell fusion was found in tumors. …”
Get full text
Article -
67
Secondary Hemophagocytic Lymphohistiocytosis: A Challenging Diagnosis in a Patient with Autoimmune Hepatitis
Published 2019-01-01“…He was treated with dexamethasone and etoposide, without bone marrow transplantation (BMT) due to poor functional status. …”
Get full text
Article -
68
Improving the Safety of Tolerance Induction: Chimerism and Cellular Co-Treatment Strategies Applied to Vascularized Composite Allografts
Published 2012-01-01“…Recently it has been demonstrated that VCAs incorporating a vascularized long bone in a rat model provide concurrent vascularized bone marrow transplantation that, itself, functions to establish hematopoietic chimerism and donor-specific tolerance following non-myeloablative conditioning of recipients. …”
Get full text
Article -
69
HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature
Published 2018-01-01“…The existing literature links GAVE to patients with cirrhosis, scleroderma, bone marrow transplantation, and chronic renal failure among other associations, but its pathophysiology remains ill-defined. …”
Get full text
Article -
70
Comparative Intracellular Cytokine Production by In Vitro Stimulated T Lymphocytes from Human Umbilical Cord Blood (HUCB) and Adult Peripheral Blood (APB)
Published 2000-01-01“…It has been suggested that there is a reduced graft‐versus‐host‐disease (GVHD) with HUCB compared to bone marrow transplantation. Since cytokine production by a cell is an indication of the cells function it is important to determinate the differences between APB and HUCB with respect to production of these soluble factors. …”
Get full text
Article -
71
Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia
Published 2020-01-01“…Idiopathic hyperammonemia is a rare but potentially fatal complication occurring in patients with acute leukemia or bone marrow transplantation. The role of some specific anticancer drugs may be discussed, but the etiology of hyperammonemia is often multifactorial. …”
Get full text
Article -
72
Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study
Published 2023-01-01“…The CR rate had statistical differences by bone marrow transplantation (BMT) and WBC count. The 2-year LFS and OS were 40% and 42%, respectively. …”
Get full text
Article -
73
-
74
ATM in immunobiology: From lymphocyte development to cancer immunotherapy
Published 2025-02-01“…The article explores ATM's significance in maintaining hematopoietic stem cell function and its implications for bone marrow transplantation and gene therapy. Additionally, it addresses ATM's involvement in inflammation and immune senescence, linking DNA damage response to age-related immune decline. …”
Get full text
Article -
75
Dynamics of Graft Function Measured by DNA-Technology in a Patient with Severe Aplastic Anemia and Repeated Stem Cell Transplantation
Published 2014-01-01“…Although bone marrow transplantation (BMT) from an HLA identical sibling is considered as treatment of choice in pediatric patients with severe aplastic anemia (SAA), a significant number of them experience graft failure (GF) after BMT. …”
Get full text
Article -
76
Stem Cell Interaction with Somatic Niche May Hold the Key to Fertility Restoration in Cancer Patients
Published 2012-01-01“…The spontaneous return of fertility after bone marrow transplantation or heterotopic grafting of cryopreserved ovarian cortical tissue has surprised many, and a possible link with stem cells has been proposed. …”
Get full text
Article -
77
-
78
Anti-Müllerian Hormone as a Sensitive Marker of Ovarian Function in Young Cancer Survivors
Published 2013-01-01“…The lowest AMH values were noted in patients after bone marrow transplantation (BMT) and those treated for Hodgkin lymphoma (HL). …”
Get full text
Article -
79
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Published 2010-01-01Get full text
Article -
80
